Nanoviricides (NNVC) Enterprise Value (2010 - 2026)
Nanoviricides' Enterprise Value came in at $28.95 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 33.5% from $21.69 million a year earlier and up 75.6% from the prior quarter.
Powered by 
Analysis
Nanoviricides (NNVC) Enterprise Value (2010 - 2026) Analysis & Trends
Going back to fiscal Q1 2011, Nanoviricides' Enterprise Value data covers 64 quarters.
- Enterprise Value has increased in each of the last three fiscal years, though with a five-year compound annual growth rate of -2.5% (FY2021 to FY2026).
- Going back by fiscal year, Enterprise Value was $21.69 million in FY2025 (+21.8%), $17.81 million in FY2024 (+235.8%), $5.3 million in FY2023 (-31.4%) and $7.73 million in FY2022 (-76.5%).
- The fiscal Q4 2026 figure represents the highest quarterly Enterprise Value since fiscal Q1 2022.
- Year-over-year, Enterprise Value has increased for 12 consecutive quarters, with growth averaging 53.1% over the last eight quarters.
- The fastest year-over-year change in Enterprise Value over five years came in fiscal Q2 2024 (growth of 361.7%), and the weakest in fiscal Q2 2023 (a decline of 94.3%).
- Business Quant data shows NNVC's Enterprise Value at $16.49 million (Q3 2026), $19.2 million (Q2 2026) and $23.98 million (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn |
| 10 | Nanoviricides | 30.08 Mn | 17.74 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.95 Mn |
| Mar 31, 2026 | 16.49 Mn |
| Dec 31, 2025 | 19.20 Mn |
| Sep 30, 2025 | 23.98 Mn |
| Jun 30, 2025 | 21.69 Mn |
| Mar 31, 2025 | 16.26 Mn |
| Dec 31, 2024 | 18.37 Mn |
| Sep 30, 2024 | 17.19 Mn |
| Jun 30, 2024 | 17.81 Mn |
| Mar 31, 2024 | 10.40 Mn |
| Dec 31, 2023 | 6.77 Mn |
| Sep 30, 2023 | 8.74 Mn |
| Jun 30, 2023 | 5.30 Mn |
| Mar 31, 2023 | 3.95 Mn |
| Dec 31, 2022 | 1.47 Mn |
| Sep 30, 2022 | 7.17 Mn |
| Jun 30, 2022 | 7.73 Mn |
| Mar 31, 2022 | 8.55 Mn |
| Dec 31, 2021 | 25.57 Mn |
| Sep 30, 2021 | 33.78 Mn |
API Access
Nanoviricides Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=NNVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "NNVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=NNVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();